 CLEARWATER, Fla.--BUSINESS WIRE--Apyx Medical Corporation NASDAQ:APYX the Company, a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market, today announced that financial results for the fourth quarter and fiscal year 2021 will be released before the market opens on Thursday, March 17th. Management will host a conference call at 8:00 a.m. Eastern Tim 